Higher rates of glaucoma therapy seen at increasing IOP levels, with cutoff of 22 mm Hg influencing clinician decision-making ...

Optical Coherence Tomography (OCT) Market Report 2025" has been added to ResearchAndMarkets.com's offering. The artificial ...

Shares of Glaukos retreated after the company forecast disappointing sequential revenue growth for its iDose product in the fourth quarter. The stock declined 12% to $97 in after-hours trading on ...

Nikkhil K Masurkar Wednesday, January 14, 2026, 08:00 Hrs [IST] Myopia is a widespread vision issue affecting over two ...

Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology focused on novel therapies for the ...

Personal Independence Payment (PIP) is a disability benefit paid to those with long-term physical or mental health conditions ...